Tag: EAU21 Virtual

12 July 2021

Determining the underlying genetic basis in male infertility

By Asst. Prof. Alekzander Khelaia (Tbilisi, GE), ESUO and ESAU member This article reflects the highlights of the lecture Asst. Prof. Alekzander
11 July 2021

Report: Plenary session 5 explores mHSPC treatments

The role of novel imaging and the treatment options for metastatic hormone-sensitive prostate cancer (mHSPC) were some of the topics
10 July 2021

Plenary session 4 report: The VHL mechanism and IMT-based management for RCC

Today, Plenary session 4 “Renal cancer: From localised to metastatic disease” zeroed in on topics such as the VHL mechanism
09 July 2021

Report: Nightmare session on early detection of prostate cancer

One of the highlights of the Annual EAU Congress is the Nightmare session. At EAU21 Virtual, too, the Nightmare session
09 July 2021

Plenary session 2 report: Incontinence care challenges and management in elderly patients

Drug-drug interactions (DDIs), expert insights on mesh usage, and the patients’ perspective were some of the topics covered today during
09 July 2021

Urine biomarkers for treatment response

Considerable unmet biomarker potential exists in the treatment of bladder cancer By Dr. Patrick Hensley (Houston, US) & Dr. Ashish M. Kamat (Houston,
09 July 2021

Antimicrobial resistance: How to deal with the pandemic

By Dr. José Medina-Polo (Madrid, ES), Associate Member of the ESIU This article reflects the highlights of the lecture Dr. José Medina-Polo
09 July 2021

Insightful and eye-opening presentations at first-ever EAU Patient Day

Today was the birth of the very first EAU Patient Day at the Annual EAU Congress. On the second day
08 July 2021

Urology beyond Europe: Different approaches, same goal

The mission of the European Association of Urology (EAU) is to raise the level of urological care throughout Europe and
08 July 2021

Incontinence mesh removal surgery in women

By Dr. Marie-Aimée Perrouin-Verbe (Nantes, FR), Department of Urology, Nantes Academic Hospital & Prof. Hashim Hashim (Bristol, GB), Bristol Urological Institute, Southmead Hospital This
08 July 2021

Using pharmacotherapy for OAB: What drug interactions to be aware of

By Prof. Martin C. Michel (Mainz, DE), Department of Pharmacology, Johannes Gutenberg University This article reflects the highlights of the lecture Prof.
07 July 2021

The PIONEER Big Data platform: How does it apply to prostate cancer?

By Dr. Susan Evans Axelsson (Malmö, SE), Clinical Coordinator PIONEER This article reflects the highlights of the lecture Dr. Susan Evans Axelsson
05 July 2021

Immunotherapy for metastatic urothelial cancer

New agents are expected to significantly improve overall prognosis By Dr. Ursula Vogl (Bellinzona, CH), medical oncologist at Ospedale San Giovanni